StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a report released on Wednesday. The firm issued a sell rating on the medical device company’s stock.

Cutera Stock Up 3.4 %

NASDAQ:CUTR opened at $0.43 on Wednesday. The firm’s fifty day simple moving average is $0.41 and its 200-day simple moving average is $0.67. The stock has a market cap of $8.63 million, a PE ratio of -0.06 and a beta of 1.31. Cutera has a fifty-two week low of $0.28 and a fifty-two week high of $3.10.

Cutera (NASDAQ:CUTR) last issued its earnings results on Thursday, November 7th. The medical device company reported ($1.94) earnings per share for the quarter, missing the consensus estimate of ($0.96) by ($0.98). The business had revenue of $32.50 million for the quarter, compared to the consensus estimate of $32.57 million. During the same quarter in the prior year, the firm earned ($2.22) EPS. Equities analysts anticipate that Cutera will post -5.78 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC boosted its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the period. Squarepoint Ops LLC owned about 0.57% of Cutera worth $172,000 at the end of the most recent reporting period. 90.70% of the stock is currently owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.